Johnson & Johnson

Pharmaceuticals

JNJ

$ 157 (0.15)%

Share price

$ 378 bn

Market Cap

$ 432 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.05x the weighted average for S&P 500

FY2021

Primary Climate Goal

Proj. YOY change in GHG emissions (Scope 1 + 2)

Weaker than the -8% weighted average for S&P 500

FY2022

Johnson & Johnson aims to reduce Scope 1 + 2 by 60% by 2030 from a base year 2016

1.5°C

GHG emissions and Carbon intensity

Johnson & Johnson reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 765 Kt (+18/+2.4% y-o-y). At the sime time, carbon intensity decreased to 8.2 t (-0.8 /-8.9% y-o-y).

Johnson & Johnson's Scope 3 emissions grew to 17,359 Kt (+864/+5.2% y-o-y). The performance has been erratic recently.

The company is committed to reducing Scope 1 + 2 by 60% by 2030 from a base year 2016, which translates into the estimated reduction of -33 Kt per annum over the period of FY2022 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	765	368	397	17,359	93,775	8.2
2020Q4	747	364	383	16,494	82,584	9
2019Q4	969	426	543	16,892	82,059	12
2018Q4	1,036	452	583	19,765	81,581	13
2017Q4	1,063	474	639	17,988	76,450	14
2016Q4	1,172	468		19,857	71,890	16

Johnson & Johnson

Carbon footprint

Primary Climate Goal

Johnson & Johnson aims to reduce Scope 1 + 2 by 60% by 2030 from a base year 2016

GHG emissions and Carbon intensity

Johnson & Johnson's carbon footprint

Company environmental metrics